INNOVIVA, INC. Dividends Per Share
INNOVIVA, INC. (INVA) reported Dividends Per Share of $0.00 per share for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-23.
Discontinued › Income Statement › Earnings Per Share
us-gaap:CommonStockDividendsPerShareDeclared · last filed 2018-02-23
- INNOVIVA, INC. common stock, dividends, per share, declared for the quarter ending 2016-12-31 was $0.00.
- INNOVIVA, INC. common stock, dividends, per share, declared for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- INNOVIVA, INC. common stock, dividends, per share, declared for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- INNOVIVA, INC. common stock, dividends, per share, declared for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- INNOVIVA, INC. common stock, dividends, per share, declared for fiscal 2017 was $0.00.
- INNOVIVA, INC. common stock, dividends, per share, declared for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- INNOVIVA, INC. common stock, dividends, per share, declared for fiscal 2015 was $0.75, a 50.00% increase from fiscal 2014.
- INNOVIVA, INC. common stock, dividends, per share, declared for fiscal 2014 was $0.50.
| Period end | Common Stock, Dividends, Per Share, Declared | Common Stock, Dividends, Per Share, Declared 3 month | Common Stock, Dividends, Per Share, Declared 6 month | Common Stock, Dividends, Per Share, Declared 9 month | Common Stock, Dividends, Per Share, Declared 12 month |
|---|---|---|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-02-23 | ||||
| 2016-12-31 | $0.00 10-K · filed 2017-02-28 | $0.00 derived: sum of 2 quarters · filed 2017-02-28 | $0.00 derived: sum of 3 quarters · filed 2017-02-28 | $0.00 10-K · filed 2018-02-23 | |
| 2016-09-30 | $0.00 10-K · filed 2017-02-28 | $0.00 derived: sum of 2 quarters · filed 2017-02-28 | $0.00 10-Q · filed 2016-11-03 | $0.00 derived: sum of 4 quarters · filed 2017-02-28 | |
| 2016-06-30 | $0.00 10-K · filed 2017-02-28 | $0.00 10-Q · filed 2016-08-04 | $0.00 derived: sum of 3 quarters · filed 2017-02-28 | $0.25 derived: sum of 4 quarters · filed 2017-02-28 | |
| 2016-03-31 | $0.00 10-K · filed 2017-02-28 | $0.00 derived: sum of 2 quarters · filed 2017-02-28 | $0.25 derived: sum of 3 quarters · filed 2017-02-28 | $0.50 derived: sum of 4 quarters · filed 2017-02-28 | |
| 2015-12-31 | $0.00 10-K · filed 2017-02-28 | $0.25 derived: sum of 2 quarters · filed 2017-02-28 | $0.50 derived: sum of 3 quarters · filed 2017-02-28 | $0.75 10-K · filed 2018-02-23 | |
| 2015-09-30 | $0.25 10-K · filed 2017-02-28 | $0.50 derived: sum of 2 quarters · filed 2017-02-28 | $0.75 10-Q · filed 2016-11-03 | $1.00 derived: sum of 4 quarters · filed 2017-02-28 | |
| 2015-07-24 | $0.25 10-K · filed 2017-02-28 | ||||
| 2015-06-30 | $0.25 10-K · filed 2017-02-28 | $0.50 10-Q · filed 2016-08-04 | $0.75 derived: sum of 3 quarters · filed 2017-02-28 | $1.00 derived: sum of 4 quarters · filed 2017-02-28 | |
| 2015-04-24 | $0.25 10-K · filed 2017-02-28 | ||||
| 2015-03-31 | $0.25 10-K · filed 2017-02-28 | $0.50 derived: sum of 2 quarters · filed 2017-02-28 | $0.75 derived: sum of 3 quarters · filed 2017-02-28 | $0.75 derived: sum of 4 quarters · filed 2017-02-28 | |
| 2015-02-20 | $0.25 10-K · filed 2017-02-28 | ||||
| 2014-12-31 | $0.25 10-K · filed 2016-02-24 | $0.50 derived: sum of 2 quarters · filed 2016-02-24 | $0.50 derived: sum of 3 quarters · filed 2016-02-24 | $0.50 10-K · filed 2017-02-28 | |
| 2014-10-16 | $0.25 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $0.25 10-K · filed 2016-02-24 | $0.25 derived: sum of 2 quarters · filed 2016-02-24 | $0.25 10-Q · filed 2015-11-05 | ||
| 2014-07-25 | $0.25 10-K · filed 2017-02-28 | ||||
| 2014-06-30 | $0.00 10-K · filed 2016-02-24 | $0.00 10-Q · filed 2015-08-06 | |||
| 2014-03-31 | $0.00 10-K · filed 2016-02-24 | ||||
| 2013-12-31 | $0.00 10-K · filed 2016-02-24 | ||||
| 2012-12-31 | $0.00 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |